|
Click to set custom HTML
|
Pathology definition - Oligodendroglioma
Red arrow indicates oligodendroglioma
Oligodendroglioma
Oligodendroglioma will present at the frontal lobe, at the white matter of the cerebral hemisphere. Oligodendroglioma is tumor that affect middle age and elderly patient.
Oligodendroglioma may present with signs and symptoms such as raised intracranial pressure and headache. Oligodendroglioma arises from oligodendrocytes. Oligodendroglioma is a benign tumor.
Oligodendroglioma consists of sheets of uniform cells with round nuclei. This is commonly known as fried egg appearance.
Oligodendroglioma is slow growing mass ( gray and circumscribed in appearance) with cyst. The tumor is calcified in nature which can be detected by imaging techniques. There will also be an increase in vascularity of the tumor.
Oligodendroglioma is treated with surgical resection of the tumor, radiation therapy and chemotherapeutic approach.
References
1.Engelhard, Herbert H, Ana Stelea, and Elizabeth J Cochran. “Oligodendroglioma: Pathology and Molecular Biology.” Surgical Neurology 58, no. 2 (August 2002): 111–117. doi:10.1016/S0090-3019(02)00751-6.
2.Bruner, J M. “Oligodendroglioma: Diagnosis and Prognosis.” Seminars in Diagnostic Pathology 4, no. 3 (August 1987): 251–261.
Oligodendroglioma will present at the frontal lobe, at the white matter of the cerebral hemisphere. Oligodendroglioma is tumor that affect middle age and elderly patient.
Oligodendroglioma may present with signs and symptoms such as raised intracranial pressure and headache. Oligodendroglioma arises from oligodendrocytes. Oligodendroglioma is a benign tumor.
Oligodendroglioma consists of sheets of uniform cells with round nuclei. This is commonly known as fried egg appearance.
Oligodendroglioma is slow growing mass ( gray and circumscribed in appearance) with cyst. The tumor is calcified in nature which can be detected by imaging techniques. There will also be an increase in vascularity of the tumor.
Oligodendroglioma is treated with surgical resection of the tumor, radiation therapy and chemotherapeutic approach.
References
1.Engelhard, Herbert H, Ana Stelea, and Elizabeth J Cochran. “Oligodendroglioma: Pathology and Molecular Biology.” Surgical Neurology 58, no. 2 (August 2002): 111–117. doi:10.1016/S0090-3019(02)00751-6.
2.Bruner, J M. “Oligodendroglioma: Diagnosis and Prognosis.” Seminars in Diagnostic Pathology 4, no. 3 (August 1987): 251–261.
